CPHI vs TPR · rev $4.1M vs P/E 46, rev $8.00B
China Pharma Holdings Inc (CPHI) versus Tapestry Inc (TPR) — a side-by-side from cached financials, not a winner call.
China Pharma Holdings Inc (CPHI) is a drug manufacturers - specialty & generic company listed on US.
Tapestry Inc (TPR) is a luxury goods company listed on NYSE.
Latest reported CPHI revenue for 2025-12-31 was $4.1M. Net income was -$3.2M. Revenue was down 8.5% from 2024-12-31 to 2025-12-31. CPHI currently screens at market cap $29.0M.
Latest reported TPR revenue for 2026-06-27 was $8.00B. Net income was $1.53B. Revenue was up 14.2% from 2025-06-28 to 2026-06-27. TPR currently screens at market cap $30.81B and trailing P/E 46.3.
CPHI currently screens at market cap $29.0M. TPR currently screens at market cap $30.81B and trailing P/E 46.3.
Not investment advice. Open the CPHI and TPR stock pages for the full models.
Not investment advice.